参考文献/References:
[1] Catanese MT,Uryu K,Kopp M,et al.Ultrastructural analysis of hepatitis C virus particles[J].Proc Natl Acad Sci USA,2013,110(23):9505-9510.
[2] Fortes P,Morris KV.Long noncoding RNAs in viral infections[J].Virus Res,2016,212:1-11.
[3] Polaris Observatory HCV Collaborators.Global prevalence and genotype distribution of hepatitis C virus infection in 2015:A modelling study[J].Lancet Gastroenterol Hepatol,2017,2(3):161-176.
[4] Llovet JM,Villanueva A.Liver cancer: Effect of HCV clearance with direct-acting antiviral agents on HCC[J].Nat Rev Gastroenterol Hepatol,2016,13(10):561-562.
[5] Stanaway JD,Flaxman AD,Naghavi M,et al.The global burden of viral hepatitis from 1990 to 2013: Findings from the Global Burden of Disease Study 2013[J].Lancet,2016,388(10049):1081-1088.
[6] Bassendine MF,Sheridan DA,Bridge SH,et al.Lipids and HCV[J].Semin Immunopathol,2013,35(1):87-100.
[7] Zeisel MB,Fofana I,Fafi-Kremer S,et al.Hepatitis C virus entry into hepatocytes:Molecular mechanisms and targets for antiviral therapies[J].J Hepatol,2011,54(3):566-576.
[8] Ploss A,Evans MJ,Gaysinskaya VA,et al.Human occludin is a hepatitis C virus entry factor required for infection of mouse cells[J].Nature,2009,457(7231):882-886.
[9] Khakoo SI,Thio CL,Martin MP,et al.HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection[J].Science,2004,305(5685):872-874.
[10] Valadkhan S,Fortes P.Regulation of the interferon response by lncRNAs in HCV infection[J].Front Microbiol,2018,9:181.
[11] Gerlach JT,Diepolder HM,Jung MC,et al.Recurrence of hepatitis C virus after loss of virus-specific CD4(+)T-cell response in acute hepatitis C[J].Gastroenterology,1999,117(4):933-941.
[12] Schulze ZWJ,Ciuffreda D,Lewis-Ximenez L,et al.Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection,but rapidly disappear from human blood with viral persistence[J].J Exp Med,2012,209(1):61-75.
[13] Day CL,Seth NP,Lucas M,et al.Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class Ⅱ tetramers[J].J Clin Invest,2003,112(6):831-842.
[14] Spizzo R,Almeida MI,Colombatti A,et al.Long non-coding RNAs and cancer: A new frontier of translational research?[J].Oncogene,2012,31(43):4577-4587.
[15] 罗国强,秦彦昌,张百平,等.长链非编码RNA-ATB在胶质瘤中的表达水平和临床意义[J].陕西医学杂志,2019,48(7):831-833,849.
[16] 胡晋平,何丽洁,王汉民.长链非编码RNA在人类疾病中的研究进展[J].陕西医学杂志,2016,45(4):503-504.
[17] Ponting CP,Oliver PL,Reik W.Evolution and functions of long noncoding RNAs[J].Cell,2009,136(4):629-641.
[18] He Y,Meng XM,Huang C,et al.Long noncoding RNAs: Novel insights into hepatocelluar carcinoma[J].Cancer Lett,2014,344(1):20-27.
[19] Derrien T,Johnson R,Bussotti G,et al.The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure,evolution,and expression[J].Genome Res,2012,22(9):1775-1789.
[20] Wang KC,Chang HY.Molecular mechanisms of long noncoding RNAs[J].Mol Cell,2011,43(6):904-914.
[21] 张春艳,颜羽昕,梁 洁,等.长链非编码RNA在肝纤维化中的作用研究进展[J].解放军医学杂志,2021,46(2):186-192.
[22] Heo MJ,Yun J,Kim SG.Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma[J].Arch Pharm Res,2019,42(1):48-62.
[23] Unfried JP,Fortes P.LncRNAs in HCV infection and HCV-related liver disease[J].Int J Mol Sci,2020,21(6):2255.
[24] Qian X,Xu C,Zhao P,et al.Long non-coding RNA GAS5 inhibited hepatitis C virus replication by binding viral NS3 protein[J].Virology,2016,492:155-165.
[25] Murray CL,Jones CT,Rice CM.Architects of assembly: Roles of flaviviridae non-structural proteins in virion morphogenesis[J].Nat Rev Microbiol,2008,6(9):699-708.
[26] Scheel TK,Rice CM.Understanding the hepatitis C virus life cycle paves the way for highly effective therapies[J].Nat Med,2013,19(7):837-849.
[27] Gupta RA,Shah N,Wang KC,et al.Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis[J].Nature,2010,464(7291):1071-1076.
[28] Li ZQ,Gu XY,Hu JX,et al.Hepatitis C virus core protein impairs metabolic disorder of liver cell via HOTAIR-Sirt1 signalling[J].Biosci Rep,2016,36(3):e00336.
[29] Barriocanal M,Fortes P.Long non-coding RNAs in Hepatitis C virus-infected cells[J].Front Microbiol,2017,8:1833.
[30] Perreira JM,Chin CR,Feeley EM,et al.IFITMs restrict the replication of multiple pathogenic viruses[J].J Mol Biol,2013,425(24):4937-4955.
[31] Narayana SK,Helbig KJ,Mccartney EM,et al.The interferon-induced transmembrane proteins,IFITM1,IFITM2,and IFITM3 inhibit hepatitis C virus entry[J].J Biol Chem,2015,290(43):25946-25959.
[32] Hattlmann CJ,Kelly JN,Barr SD.TRIM22: A diverse and dynamic antiviral protein[J].Mol Biol Int,2012,2012:153415.
[33] Yang C,Zhao X,Sun D,et al.Interferon alpha(IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A[J].Cell Mol Immunol,2016,13(1):94-102.
[34] Hertzog PJ,Williams BR.Fine tuning type Ⅰ interferon responses[J].Cytokine Growth Factor Rev,2013,24(3):217-225.
[35] Ivashkiv LB,Donlin LT.Regulation of type I interferon responses[J].Nat Rev Immunol,2014,14(1):36-49.
[36] Schneider WM,Chevillotte MD,Rice CM.Interferon-stimulated genes: A complex web of host defenses[J].Annu Rev Immunol,2014,32:513-545.
[37] Xie Q,Chen S,Tian R,et al.Long noncoding RNA ITPRIP-1 positively regulates the innate immune response through promotion of oligomerization and activation of MDA5[J].J Virol,2018,92(17):e00507-e00518.
[38] Zhou Y,Li M,Xue Y,et al.Interferon-inducible cytoplasmic lncLrrc55-AS promotes antiviral innate responses by strengthening IRF3 phosphorylation[J].Cell Res,2019,29(8):641-654.
[39] Jiang M,Zhang S,Yang Z,et al.Self-recognition of an inducible host lncRNA by RIG-I feedback restricts innate immune response[J].Cell,2018,173(4):906-919.
[40] Fan J,Cheng M,Chi X,et al.A human long non-coding RNA lncATV promotes virus replication through restricting RIG-I-mediated innate immunity[J].Front Immunol,2019,10:1711.
[41] Peng X,Gralinski L,Armour CD,et al.Unique signatures of long noncoding RNA expression in response to virus infection and altered innate immune signaling[J].Mbio,2010,1(5):e00206-e00210.
[42] Josset L,Tchitchek N,Gralinski LE,et al.Annotation of long non-coding RNAs expressed in collaborative cross founder mice in response to respiratory virus infection reveals a new class of interferon-stimulated transcripts[J].RNA Biol,2014,11(7):875-890.
[43] Kambara H,Niazi F,Kostadinova L,et al.Negative regulation of the interferon response by an interferon-induced long non-coding RNA[J].Nucleic Acids Res,2014,42(16):10668-10680.
[44] Carnero E,Barriocanal M,Segura V,et al.Type I interferon regulates the expression of long non-coding RNAs[J].Front Immunol,2014,5:548.
[45] Barriocanal M,Carnero E,Segura V,et al.Long non-coding RNA BST2/BISPR is induced by IFN and regulates the expression of the antiviral factor tetherin[J].Front Immunol,2014,5:655.
[46] Kambara H,Gunawardane L,Zebrowski E,et al.Regulation of interferon-stimulated gene BST2 by a lncRNA transcribed from a shared bidirectional promoter[J].Front Immunol,2014,5:676.
[47] Neil SJ,Zang T,Bieniasz PD.Tetherin inhibits retrovirus release and is antagonized by HIV-1 vpu[J].Nature,2008,451(7177):425-430.
[48] Dafa-Berger A,Kuzmina A,Fassler M,et al.Modulation of hepatitis C virus release by the interferon-induced protein BST-2/tetherin[J].Virology,2012,428(2):98-111.
[49] Ouyang J,Zhu X,Chen Y,et al.NRAV,a long noncoding RNA,modulates antiviral responses through suppression of interferon-stimulated gene transcription[J].Cell Host Microbe,2014,16(5):616-626.
[50] Carnero E,Barriocanal M,Prior C,et al.Long noncoding RNA EGOT negatively affects the antiviral response and favors HCV replication[J].EMBO Rep,2016,17(7):1013-1028.
相似文献/References:
[1]罗国强,秦彦昌,张百平,等.长链非编码RNA-ATB在胶质瘤中的表达水平和临床意义[J].陕西医学杂志,2019,(7):831.
LUO Guoqiang,QIN Yanchang,ZHANG Baiping,et al.Expression level and clinical significance of long non-coding RNA ATB in gastric cancer[J].,2019,(3):831.
[2]车 宇,梁 静△,杨怡萍,等.沉默TUG1基因对肝门部胆管癌QBC939细胞增殖、凋亡及周期的影响[J].陕西医学杂志,2020,49(5):538.
CHE Yu,LIANG Jing,YANG Yiping,et al.Effects of silencing TUG1 on the proliferation,apoptosis and cell cycle of QBC939 cells[J].,2020,49(3):538.
[3]舒 放,王海峰,薛飞肖,等.乙型肝炎病毒S基因不同区域嵌合丙型肝炎病毒中和抗原表位病毒样颗粒实验研究[J].陕西医学杂志,2021,50(6):660.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.005]
SHU Fang,WANG Haifeng,XUE Feixiao,et al.Comparison of chimeric virus-like particles of HCV neutralizing epitopes in different regions of HBV S gene[J].,2021,50(3):660.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.005]
[4]洪 甲,杨 洋,栾丽霞.lncRNA-p23154通过miR-375/KLF4途径对SKOV3细胞增殖、侵袭的影响[J].陕西医学杂志,2021,50(11):1336.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.004]
HONG Jia,YANG Yang,LUAN Lixia.Effect of lncRNA-p23154 on proliferation and invasion of SKOV3 cells through miR-375/Krüppel-like factor 4 pathway[J].,2021,50(3):1336.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.004]
[5]刘 娟,康星星.人类免疫缺陷病毒感染/获得性免疫缺陷综合征患者476例乙型、丙型肝炎病毒及梅毒螺旋体感染情况调查研究[J].陕西医学杂志,2021,50(12):1598.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.033]
LIU Juan,KANG Xingxing.Investigation on HBV,HCV and TP infection in 476 HIV/AIDS patients[J].,2021,50(3):1598.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.033]
[6]张 媛,马 媛,鲁 杨,等.长链非编码RNA-kcnq1重叠转录物1通过负性调控miR-19a表达对人脐静脉内皮细胞功能影响实验研究[J].陕西医学杂志,2022,51(8):939.[doi:DOI:10.3969/j.issn.1000-7377.2022.08.008]
ZHANG Yuan,MA Yuan,LU Yang,et al.Effect of long non-coding RNA-kcnq1ot1 on the function of human umbilical vein endothelial cells by negatively regulating miR-19a expression[J].,2022,51(3):939.[doi:DOI:10.3969/j.issn.1000-7377.2022.08.008]
[7]张 璐,郭含梦,王庆义.长链非编码RNA母系表达基因8通过微小RNA-495-3p调控急性髓性白血病细胞高迁移率族蛋白A1表达及对细胞增殖、凋亡的作用机制研究[J].陕西医学杂志,2024,(7):895.[doi:DOI:10.3969/j.issn.1000-7377.2024.07.006]
ZHANG Lu,GUO Hanmeng,WANG Qingyi.LncRNA MEG8 regulates HMGA1 expression and the mechanism of cell proliferation and apoptosis in acute myeloid leukemia cells through miR-495-3p[J].,2024,(3):895.[doi:DOI:10.3969/j.issn.1000-7377.2024.07.006]
[8]王兴健,周巧艳,颜伟健,等.长链非编码lnc-FAF通过调控微小RNA-302a-3p保护缺氧复氧诱导肾小管上皮细胞的损伤[J].陕西医学杂志,2025,54(4):452.[doi:DOI:10.3969/j.issn.1000-7377.2025.04.004]
WANG Xingjian,ZHOU Qiaoyan,YAN Weijian,et al.Lnc-FAF protects renal tubular epithelial cells from hypoxia-reoxygenation-induced injury by regulating miR-302a-3p[J].,2025,54(3):452.[doi:DOI:10.3969/j.issn.1000-7377.2025.04.004]